We are live on ! Find out more
NUS icon

Nu Skin

200 hedge funds and large institutions have $259M invested in Nu Skin in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 77 increasing their positions, 59 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

980% more call options, than puts

Call options by funds: $324K | Put options by funds: $30K

31% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 59

7% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 41

1% less funds holding

Funds holding: 203200 (-3)

2.06% less ownership

Funds ownership: 77.81%75.75% (-2.1%)

9% less capital invested

Capital invested by funds: $285M → $259M (-$25.6M)

Holders
200
Holders Change
-3
Holders Change %
-1.48%
% of All Funds
2.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
38
Increased
77
Reduced
59
Closed
41
Calls
$324K
Puts
$30K
Net Calls
+$294K
Net Calls Change
+$777K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$2.8M +$1.19M +173,710 +75%
Jane Street
27
Jane Street
New York
$2.2M -$4.17M -605,764 -65%
EGM
28
Engineers Gate Manager
New York
$1.96M +$351K +50,989 +22%
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.85M -$21.2K -3,079 -1%
Walleye Capital
30
Walleye Capital
New York
$1.76M -$233K -33,900 -12%
Ameriprise
31
Ameriprise
Minnesota
$1.64M +$877K +127,474 +115%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$1.59M +$605K +87,941 +61%
AQR Capital Management
33
AQR Capital Management
Connecticut
$1.45M +$425K +61,787 +41%
HF
34
HRT Financial
New York
$1.43M -$1.45M -210,531 -50%
BCM
35
Bridgeway Capital Management
Texas
$1.4M
Citadel Advisors
36
Citadel Advisors
Florida
$1.35M -$4.11M -597,052 -75%
N
37
Nuveen
North Carolina
$1.33M
ECM
38
ExodusPoint Capital Management
New York
$1.3M -$22.7K -3,301 -2%
Squarepoint
39
Squarepoint
New York
$1.24M +$293K +42,601 +31%
SEI Investments
40
SEI Investments
Pennsylvania
$1.22M +$156K +22,660 +15%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$1.18M -$85.1K -12,380 -7%
Bank of America
42
Bank of America
North Carolina
$1.07M -$442K -64,302 -29%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$954K +$395K +57,443 +71%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$893K +$891K +129,553 New
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$871K +$624K +90,707 +251%
Creative Planning
46
Creative Planning
Kansas
$855K +$570K +82,930 +201%
Prudential Financial
47
Prudential Financial
New Jersey
$775K -$374K -54,400 -33%
A
48
AlphaQuest
New York
$746K +$494K +71,864 +198%
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
$727K +$35.8K +5,209 +5%
GCM
50
Graham Capital Management
Connecticut
$716K +$626K +91,009 +704%

NUS Hedge Fund Activity: Q4 2024 in Review

200 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Nu Skin (NUS) for Q4 2024, worth a combined $259M — down 9% from $285M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of NUS and 38 opened new positions — a net loss of 3 holders — while 59 trimmed existing stakes and 77 added.

The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $6.68M. The largest seller was Vanguard Group, cutting an estimated $8.01M.

  • 200 institutional investors held Nu Skin (NUS) as of Q4 2024, down from 203 in Q3 2024.
  • Funds reported $259M of Nu Skin stock for Q4 2024, down 9% quarter-over-quarter.
  • 38 funds opened new Nu Skin positions in Q4 2024 and 41 closed out, a net change of -3 holders.
  • The largest Nu Skin buyer in Q4 2024 was Hotchkis & Wiley Capital Management, an estimated $6.68M added.
  • The largest Nu Skin seller in Q4 2024 was Vanguard Group, an estimated $8.01M sold.

Based on aggregated 13F filings for Q4 2024.